Sign in

CIK 0001321834 · Non-accelerated filer<br>Smaller reporting company

Q/C TECHNOLOGIES, INC.

Sign in to watch
Ticker
QCLS
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
856-848-8698
Business address
1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
Former names
Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
  1. 8-K Event Director nominations
  2. 8-K Event Other events
  3. EFFECT Other Notice of Effectiveness
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. S-3/A Offering Registration Statement
  7. UPLOAD Other SEC-generated Letter
  8. SC 13G Stake Amended Statement of Ownership
  9. S-3 Offering Registration Statement
  10. D Other Notice of Sales of Unregistered Securities
  11. 8-K Event Other events
  12. 8-K Event Other events
  13. 424B5 Offering Prospectus
  14. 10-Q Report Quarterly Report
  15. 8-K Event Material agreement · Unregistered share sale · Other events
  16. 8-K Event Material agreement · Other events
  17. SC 13G/A Stake Amended Statement of Ownership
  18. SC 13G/A Stake Amended Statement of Ownership
  19. SC 13G Stake Amended Statement of Ownership
  20. 8-K Event Other events

Page 17 of 31 · 604 filings